Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on December 12, 2012, covering events occurring on December 10, 2012. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased its size from nine to ten members.
- New Director Appointment: Gail K. Boudreaux was elected to fill the new vacancy, with a term expiring at the 2013 annual meeting of stockholders.
- Committee Assignments: Ms. Boudreaux was appointed to the Compensation and Management Development Committee and the Corporate Governance Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of market risks. Regarding contingencies and unusual items, the company confirmed there are no arrangements or understandings between Ms. Boudreaux and other persons regarding her appointment, and she holds no direct or indirect material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K. Ms. Boudreaux will participate in standard non-employee director compensation arrangements and is expected to execute the standard indemnification agreement.
Key Facts for Investor Verification
- Verify the effective date of Gail K. Boudreaux's board membership and committee assignments.
- Review the definitive proxy statement filed on March 23, 2012, for details on non-employee director compensation.
- Confirm the terms of the standard non-employee director indemnification agreement referenced from the July 31, 2008 filing.
- Note that this filing does not contain financial results; refer to the most recent 10-Q or 10-K for financial data.